Navigation Links
Melanoma and Pregnancy: What Every Woman Needs to Know About the Risks, Prognosis
Date:5/4/2009

SCHAUMBURG, Ill., May 4 /PRNewswire-USNewswire/ -- Researchers estimate that nearly one-third of cases of melanoma, the most serious form of skin cancer, are diagnosed in women during their childbearing years. Since many women now are delaying pregnancy until their 30s or 40s, coupled with the fact that melanoma is the most common form of cancer for young adults 25-29 years old, more women could be faced with developing melanoma before or during pregnancy.

At the recent 67th Annual Meeting of the American Academy of Dermatology, dermatologist Marcia S. Driscoll, MD, FAAD, clinical associate professor of dermatology at the University of Maryland School of Medicine in Baltimore, presented evidence concerning the prognosis for women who become pregnant after surviving melanoma and for those who develop melanoma during pregnancy.

"Over the years, there has been ongoing controversy concerning the effect of hormones on melanoma," said Dr. Driscoll. "Some researchers speculated that melanomas may grow rapidly and spread due to the hormones associated with pregnancy. While we know that hormones may impact other types of cancer, such as breast and ovarian cancer, a review of the research on pregnancy and melanoma shows there is no evidence that pregnancy has an adverse influence either on the prognosis of melanoma or the risk of developing melanoma."

Prognosis Important when Considering Pregnancy after Melanoma

Dr. Driscoll explained that the best direct evidence of the prognosis for the woman who becomes pregnant after being diagnosed with melanoma is based on three small case-controlled studies. Reviewed collectively, these
'/>"/>

SOURCE American Academy of Dermatology
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
2. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
3. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
4. Large Blinded Clinical Study Achieves High Accuracy for the Diagnosis of Melanoma Using In Vivo Confocal Microscopy
5. Recipient of Melanoma Drug in Development Celebrates Two Cancer-Free Years
6. Authorization for AGENDA Phase 3 Trial of Genasense(R) in Advanced Melanoma Granted by French Regulatory Agency
7. CuraGen Announces Presentation of Phase I Dose-Escalation Results on CR011- vcMMAE for Metastatic Melanoma
8. Genasense(R) Data in Patients with Advanced Melanoma to be Featured at 4th International Melanoma Congress
9. IDM Pharma Announces Updated Phase 2 UVIDEM(R) Results Showing Durable Disease Control and Tolerability in Advanced Melanoma Patients
10. FDA to Extend Review of Data Quality Submission for Genasense(R) in Melanoma
11. AmpliMed Corporation Announces Promising 1-year Survival Data from Phase I/II Study of Amplimexon(R) in Metastatic Malignant Melanoma

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...EWYORK,Nov.25/PRNewswire/--Reportlinker.comannounc...logue: ,, IntranasalDrugDelivery-USMarketTrend...67/Intranasal-Drug-Delivery---US-Market-Trends--An...etiswitnessinganexpansionoftherapeuticapplications...tothedeliveryofsystemictherapeuticdrugs.Thefutureo...
(Date:11/25/2009)...OUNTAINVIEW,Calif.,Nov.25/PRNewswire/-- ChemoCent...fromtheCompany,sPROTECT-1(theProspectiveRandomized...cet-EN(TM)(CCX282-B)inpatientswithmoderate-to-seve...avorablesafetyandtolerabilityprofile.Thestudydemon...iseaseseverityasdefinedasa70-pointdecreaseintheCro...
(Date:11/24/2009)...RVINE,Calif.,Nov.24/PRNewswire-FirstCall/--Endolog...etreatmentsforaorticdisorders,announcedtodaythatit...n,thepatentinfringementlawsuitbroughtagainstitinOc...atesDistrictCourtinIndianapolis,Indiana. ,, End...eUnitedStatesPatentandTrademarkOffice(USPTO)conduc...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues 3B Improved Bottom Line 14741 1ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues 3B Improved Bottom Line 14741 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues 3B Improved Bottom Line 14741 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues 3B Improved Bottom Line 14741 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues 3B Improved Bottom Line 14741 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues 3B Improved Bottom Line 14741 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues 3B Improved Bottom Line 14741 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues 3B Improved Bottom Line 14741 8ARKRAY Inc Receives FDA Clearance for New GLUCOCARD 28R 29 Vital 28TM 29 Blood Glucose Monitoring System 6035 1ARKRAY Inc Receives FDA Clearance for New GLUCOCARD 28R 29 Vital 28TM 29 Blood Glucose Monitoring System 6035 2ResMed Inc Announces Record Financial Results for the Quarter Ended September 30 2009 6030 1ResMed Inc Announces Record Financial Results for the Quarter Ended September 30 2009 6030 2ResMed Inc Announces Record Financial Results for the Quarter Ended September 30 2009 6030 3ResMed Inc Announces Record Financial Results for the Quarter Ended September 30 2009 6030 4ResMed Inc Announces Record Financial Results for the Quarter Ended September 30 2009 6030 5ResMed Inc Announces Record Financial Results for the Quarter Ended September 30 2009 6030 6ResMed Inc Announces Record Financial Results for the Quarter Ended September 30 2009 6030 7
...ril 23, 2007 /PRNewswire/ -- Sirion Therapeutics,a...ipeline,compounds, ST-601 (difluprednate) and ST-6...nual meeting of The Association for,Research in Vi...L.,In addition to these presentations, the company... ST-601 (difluprednate) is currently being evaluat...
...alyses To Be Presented --, SAN FRANCISCO, April 24...today announced that data from the Company,s Phase...sease will be,presented for the first time in the ...,s 59th Annual Meeting in Boston on Thursday,May ...l include new,data from both the mild and moderate...
Other Medicine Technology:Sirion Therapeutics Announces Clinical Data to be Presented at the,2007 Association for Research in Vision and Ophthalmology (ARVO),Annual Meeting 2Sirion Therapeutics Announces Clinical Data to be Presented at the,2007 Association for Research in Vision and Ophthalmology (ARVO),Annual Meeting 3Sirion Therapeutics Announces Clinical Data to be Presented at the,2007 Association for Research in Vision and Ophthalmology (ARVO),Annual Meeting 4Medivation Announces First U.S. Presentation of Data From Dimebon,Phase 2 Alzheimer's Disease Trial at American Academy of Neurology,Annual Meeting 2Medivation Announces First U.S. Presentation of Data From Dimebon,Phase 2 Alzheimer's Disease Trial at American Academy of Neurology,Annual Meeting 3
(Date:11/26/2009)... Benton Communications announces a h... system for retailers struggling to make an econom...vember 26, 2009 -- Flu fears is the type of challe...ergency room, according to Dr. David Benton, busin... business growth system – The Rfactor Inten...
(Date:11/25/2009)...SASCITY,Mo.,Nov.25/PRNewswire/--TheBartleHallConve...medicalcliniconDec.9-10,whenKansasCityhoststhelate... ,, "Thisfreecliniceventhasthepotentialtobetheb...ofjustoneandbeheldonweekdaysinsteadofoveraweekend,...lthClinicandpresidentoftheNationalAssociationofFre...
(Date:11/25/2009)...ONTO,Nov.25/PRNewswire/-SentinelleMedicalInc.,alea...zationsoftwarelaunchesasuiteofnewleadingedgeclinic...platformatthisyear,sRadiologicalSocietyofNorthAmer...Booth5800,HallA).Theapplicationsleveragetheuniqueh...MRIimagingcoilsandsupportmultipleimagingmodalities...
(Date:11/25/2009)...ANGELES,Nov.25/PRNewswire-USNewswire/--TheBlackAID...termineexecutiveleadershipfor2010. ,, ThenewBoa...ltiesinpublicpolicy,law,finance,governmenthealthpr...ardalsocomesfromawiderangeofpersonalbackgroundsinc...ivingwithHIVthemselves,andrepresentingmultipleageg...
(Date:11/25/2009)... survivors of testicular cancer who were treated w...ide effects, including neurological side effects a...reated with chemotherapy, according to a new study...he National Cancer Institute . , Marianne Brydy,...iversity Hospital, in Bergen, Norway, and colleagu...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2
...w scientists are confirming in laboratory studies ...duct collected from beehives--may inhibit the deve...ity of Campinas, Brazil, found that propolis// con...ucrose and promote the binding of cariogenic bacte...
...cording to researchers a new has been found way of... into cartilage that could be used to repair knee ...al of tissue engineering where replacement// or re...pmental pathways - to become more specialised. ...
...ur people are confirmed dead from pneumonic plague... of the plague from a remote village of Himachal P...ptoms of pneumonic plague. // "The sequence o...C.P. Thakur said. "The good news is that the disea...
...male circumcision, or mutilation of the genitals ..., the Middle East and large areas of Africa. Parti...nd religious reasons, but rivals// say that not on...of the tip of the clitoris; Total removal of the c...
...cording to doctors at the research center the radi...sarcoma is an unusual tumour of the bone which is ...r, one case in ten proves resistant to these thera... other treatments and had multiple bone cancer sit...
.... Reddy's Laboratories (DRL) has been slapped with... AAI Pharma Inc for the generic version of the ant...sivity to sell the drug's 40 mg dosage form along ... the patent expiry allows the patent holder to fil...
Other Medicine News:
Qwik-Let® Premier
Finnpipette Techpette Single Channel, 5-50ul
...he range from 2ul to 5000ul. Fills and empties th...advertent volume change. Novel hand grip shape re...lavable at 121C(250F). To prevent corrosion the t...-handed operation. Auto or Normal trigger mode. ...
...om Thermo Labsystems was designed specifically to .... Advanced features such as the new fast dial sys...mes help to define this as a new leader in single ...late offers a custom fit for different hand sizes....
Medicine Products: